More articles from Bronchiectasis

Pulmonary exacerbations in insured patients with bronchiectasis over 2 years
Patrick A. Flume, Joseph Feliciano, Matthew Lucci, Jasmanda Wu, Sebastian Fucile, Mariam Hassan, Anjan Chatterjee

ERJ Open Research Jul 2023, 9 (4) 00021-2023; DOI: 10.1183/23120541.00021-2023
Endobronchial optical coherence tomography or computed tomography for evaluating progression of bronchiectasis
Lin-ling Cheng, Wei-jie Guan, Chang-hao Zhong, Chong-yang Duan, Zhu-quan Su, Shi-yue Li, Nan-shan Zhong

ERJ Open Research May 2023, 9 (3) 00490-2022; DOI: 10.1183/23120541.00490-2022
Patient attitudes to nebulised antibiotics in the treatment of bronchiectasis: a mixed-methods study
John Davison, Anna Robinson-Barella, Gareth Davies, Marina Campos-Hinojosa, Camille Collins, Andy Husband, Daniel Okeowo, Katy L.M. Hester, Richard Lee, Tim Rapley, Anthony De Soyza

ERJ Open Research May 2023, 9 (3) 00735-2022; DOI: 10.1183/23120541.00735-2022
The Bronchiectasis Exacerbation Diary: a novel patient-reported outcome for non-cystic fibrosis bronchiectasis
Vivian H. Shih, Maria Jison, Erik Bark, Meredith Venerus, Oren Meyers, James D. Chalmers

ERJ Open Research May 2023, 9 (3) 00712-2022; DOI: 10.1183/23120541.00712-2022
Airway clearance treatments in bronchiectasis: feasibility of linking survey results to registry data and a survey of patients’ and physiotherapists’ practices
Rebecca H. McLeese, Katherine O'Neill, Brenda O'Neill, James D. Chalmers, Jeanette Boyd, Anthony De Soyza, Ryan McChrystal, Megan L. Crichton, Judy M. Bradley

ERJ Open Research Mar 2023, 9 (2) 00540-2022; DOI: 10.1183/23120541.00540-2022
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
Stefano Aliberti, Francesco Amati, Andrea Gramegna, Barbara Vigone, Martina Oriano, Giovanni Sotgiu, Marco Mantero, Edoardo Simonetta, Laura Saderi, Anna Stainer, Serena Tammaro, Paola Marchisio, Eva Polverino, James D. Chalmers, Francesco Blasi

ERJ Open Research Jan 2022, 8 (1) 00388-2021; DOI: 10.1183/23120541.00388-2021
Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis
Emily Henkle, Charles L. Daley, Jeffrey R. Curtis, Benjamin Chan, Timothy R. Aksamit, Kevin L. Winthrop

ERJ Open Research Jan 2022, 8 (1) 00786-2020; DOI: 10.1183/23120541.00786-2020
Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis
Frederick Jung, Leonard Riley, Jorge Lascano

ERJ Open Research Jan 2022, 8 (1) 00607-2021; DOI: 10.1183/23120541.00607-2021
4-week daily airway clearance using oscillating positive-end expiratory pressure versus autogenic drainage in bronchiectasis patients: a randomised controlled trial
Galit Livnat, Naama Yaari, Nili Stein, Lea Bentur, Moneera Hanna, Maya Harel, Yochai Adir, Michal Shteinberg

ERJ Open Research Oct 2021, 7 (4) 00426-2021; DOI: 10.1183/23120541.00426-2021
Sputum procalcitonin: a potential biomarker in stable bronchiectasis
William Good, Gene Jeon, Irene Zeng, Louanne Storey, Helen Qiao, Stuart Jones, Sarah Mooney, Lata Jayaram, David Holland, Conroy Wong

ERJ Open Research Oct 2021, 7 (4) 00285-2021; DOI: 10.1183/23120541.00285-2021

Main menu

User menu

Search

More articles from Bronchiectasis

Pages

Contact us